Female contraceptive clinical trial: a rondomized controlled study of the efficacy, safety, and acceptability of C31G
Ended Awarded Last action
- Contract number
- HHSN275200403372IHHSN27500002
- Awardee
-
Magee-Womens Research Institute And Foundation UEI J3Z5MNJJ3FZ4
- Awarding agency
-
National Institute of Child Health and Human Development
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,414,847
Award facts
- Opportunity
-
- RFPNICHD200304 Solicitation number
- Contract value 89% obligated
- $1,585,279.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- Not on record
- Set-aside
- No set-aside
- Competition
- Competitive Delivery Order · 13 offers
- Pricing
- Cost No Fee
- Place of performance
- Pittsburgh, PA 15213, USA
- Legislative mandates
-
- Other statutory authority
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$170,432 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $347,804 | |
| Funding Only Action | $275,307 | |
| Supplemental Agreement for work within scope | $0 | |
| Change Order | $36,450 | |
| Funding Only Action | $392,712 | |
| Funding Only Action | $366,240 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $166,766 |
About this award
This federal contract award was issued by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services, to the Magee-Womens Research Institute and Foundation, a non-profit research organization. The $1,585,279 delivery order contract is for a randomized controlled clinical trial to evaluate the efficacy, safety, and acceptability of the C31G female contraceptive. The contract has no set-aside designation and was awarded on April 1, 2004, with a completion date of November 28, 2012.
Magee-Womens Research Institute and Foundation has an indefinite delivery contract vehicle with NICHD to participate in the Contraceptive Clinical Trials Network, a $5 million IDIQ contract that allows the institute to compete for task orders to conduct Phase I-IV clinical trials of female contraceptive drugs and devices. This contract award demonstrates the institute's ongoing role in federally-funded contraceptive research and development efforts.
Quick answers
Who was awarded contract HHSN275200403372IHHSN27500002?
HHSN275200403372IHHSN27500002 was awarded to Magee-Womens Research Institute And Foundation by National Institute of Child Health and Human Development (National Institutes of Health) on April 1, 2004.
How much is contract HHSN275200403372IHHSN27500002 worth?
The government has obligated $1,414,847 on HHSN275200403372IHHSN27500002. Its current value, with exercised options, is $1,585,279.
Is contract HHSN275200403372IHHSN27500002 an order under another contract?
Yes. HHSN275200403372IHHSN27500002 is a delivery order under HHSN275200403372I, an indefinite delivery contract.
Was contract HHSN275200403372IHHSN27500002 competed?
The extent of competition for HHSN275200403372IHHSN27500002 was competitive delivery order. The government received 13 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award